A Single-Arm, Open-Label Phase 1 Study of Itacitinib (ITA) with Calcineurin Inhibitor (CNI)-Based Interventions for Prophylaxis of Graft-Versus-Host Disease (GVHD; GRAVITAS-119)
Year: 2020
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Hannah Choe, Nirav N. Shah, Patrice Chevallier, Marie Thérèse Rubio, Mark A. Schroeder, Nancy M. Hardy, Patrick J. Stiff, Carlos Solano, Ibrahim Yakoub-Agha, Jonathan A. Gutman, Scott D. Rowley, Maria Caterina Mico', Elisabetta Terruzzi, Rafael F. Duarte, Rodica Morariu-Zamfir, Michael Arbushites, Kai Ding, Miguel-Angel Perales
Institutions: The Ohio State University, Froedtert Hospital, Medical College of Wisconsin, Centre Hospitalier Universitaire de Nantes, Nantes Université, Centre Hospitalier Régional et Universitaire de Nancy, Washington University in St. Louis, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Loyola University Medical Center, Universitat de València, Hospital Clínico Universitario de Valencia, Inserm, Université de Lille, Centre Hospitalier Universitaire de Lille, Institute for Translational Research in Inflammation, University of Colorado Cancer Center, Hackensack University Medical Center, Ospedale Papa Giovanni XXIII, Azienda Ospedaliera San Gerardo, Hospital Universitario Puerta de Hierro Majadahonda, Incyte (United States), Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3097330202